Mutational Testing

State of the GIST Community Part 3: What do we know about mutational testing?
State of the GIST Community Part 3: What do we know about mutational testing?

Mutational Testing, News

State of the GIST Community Part 3: What do we know about mutational testing?

As of May 1, 2011, the LRG patient registry only received 377 reports of mutations out of 1,327 patients, which only represents 28 percent of the entire registry. Part of this may be related to the fact that mutational testing is not common practice at diagnosis.

By Magda Sarnas|2019-04-05T09:20:33-04:00June 1st, 2011|Mutational Testing, News|

PDGFRA Mutations: It’s time to consider mutational status for resistant GIST patients
PDGFRA Mutations: It’s time to consider mutational status for resistant GIST patients

Diagnosis, GIST Education, Mutational Testing, Research, Survival Strategies

PDGFRA Mutations: It’s time to consider mutational status for resistant GIST patients

January 6th, 2011 - By Jerry Call, LRG Science CoordinatorThe first ever clinical trial specifically for the PDGFRA D842V mutation has been announced by Arog pharmaceuticals. The phase II trial is scheduled to open in [...]

By Jerry Call|2019-09-23T11:20:04-04:00January 6th, 2011|Diagnosis, GIST Education, Mutational Testing, Research, Survival Strategies|